Combination of tulmimetostat and PD-1 blockade for patients with advanced non–small cell lung cancer who progressed from first or second line of treatments.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Daniel Sanghoon Shin, Tianhong Li, Garth Strohbehn, Paul Cheng, Kevin Zheng, Hannah Tavalire, Tassos C. Kyriakides, Nithya Ramnath, Pankaj Gupta
Institutions: VA Greater Los Angeles Healthcare System, UC Davis Comprehensive Cancer Center, University of California, Davis, Yale University, University of California San Diego, VA Connecticut Healthcare System, Aurora Health Care, VA Ann Arbor Healthcare System, Ann Arbor VA Medical Center, Tibor Rubin VA Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162698227
